Boston Scientific Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Boston Scientific Corporation income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue20.0716.7514.2412.6811.899.9110.749.82
Cost of Revenue5.986.484.353.963.713.513.122.88
Gross Profit14.1010.279.908.738.186.407.626.94
Operating Expenses
Research & Development2.051.621.411.321.201.141.171.11
Selling, General & Administrative6.895.985.194.524.363.793.943.57
Operating Expenses9.847.637.556.696.356.536.105.28
Operating Income4.262.642.342.031.82-0.081.521.66
Other Income/Expense
Interest Income0.000.110.020.010.000.000.000.00
Interest Expense-0.350.39-0.270.470.34-0.360.000.24
Other Income/Expense-0.08-0.350.12-0.43-0.410.000.430.00
Income
Income Before Tax3.392.281.991.141.08-0.080.691.42
Income Tax Expense0.490.440.390.440.040.00-4.01-0.25
Net Income2.901.851.570.701.04-0.084.701.67
Net Income - Continuous Operations0.001.851.590.701.040.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA5.603.942.232.752.511.412.222.56
EBIT4.263.252.231.611.420.281.161.66
Depreciation & Amortization1.341.270.830.800.740.790.700.60
Earnings Per Share
Basic EPS2.001.001.00-1.00-3.001.00
Diluted EPS2.001.001.00-1.00-3.001.00
Basic Shares Outstanding1.481.471.451.431.421.421.391.38
Diluted Shares Outstanding1.491.491.461.441.431.421.411.40